The Effect of Noxipoint Therapy Versus Physical Therapy With TENS on Chronic Neck Pain
The Effect of Noxipoint™ Therapy Versus Physical Therapy With Transcutaneous Electrical Never Stimulation on Chronic Cervical Pain
1 other identifier
interventional
42
1 country
1
Brief Summary
Chronic cervical pain is a common problem in rehabilitation clinic, but the treatment is time consuming and the effect unsatisfactory. Noxipoint® Therapy, developed by Dr. Charles C. Koo, is a unique electrical stimulation precisely on corresponding "Noxipoints®" of each injured soft tissue, with specific duration and intensity of TENS that induce C-fiber nerve ending sensation. Each application typically last for 2 to 5 minutes. Based on observations of the clinical application, Noxipoint® Therapy appears to relieve chronic neck and shoulder pain significantly with lasting effect, and effectively improves the range of motion. However, large-scale double-blinded, randomized control study on the therapy is not available yet. The purpose of this study is to compare the effect of Noxipoint® Therapy and physical therapy (including the current TENS application) on patients with chronic neck pain. This study is a prospective stratified randomized control trial. Eighty subjects with chronic cervical pain will be recruited from the Rehabilitation Department or the Physical Therapy Center of National Taiwan University Hospital (NTUH). The qualified subjects will be stratified and randomly allocated into two arms, 40 persons in each:
- 1.Physical Therapy group (PT)
- 2.Noxipoint Therapy group (NT) Subjects in either group will be treated for up to 6 sessions within 3 weeks, about 1.5 hours per session. The treatment will terminate after six sessions or earlier if the patient shows no symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 22, 2013
CompletedFirst Posted
Study publicly available on registry
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedDecember 2, 2014
December 1, 2014
1.5 years
April 22, 2013
December 1, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of Brief Pain Index (BPI) At Its Worst from baseline to 4 weeks
BPI At Its Worst will be assessed before the first treatment and followed up at 4 weeks after the start.
About 4 weeks after the initial treatment
Secondary Outcomes (12)
Change of the normalized Range of motion(ROM) of the neck from baseline to follow-up at 4 weeks
About 4 weeks after the initial session
Change of BPI Average from baseline to the follow-up at 4 weeks
4 weeks after the initial treatment
Change of BPI-Right-Now from baseline to the follow-up at 4 weeks
4 weeks after the initial treatment
Change of BPI-Average from baseline to the follow-up at 8 weeks
8 weeks after the initial treatment
Change of BPI-Right-Now from baseline to the follow-up at 8 weeks
8 weeks after the initial treatment
- +7 more secondary outcomes
Study Arms (2)
Physical therapy arm (PT)
ACTIVE COMPARATOR* The TENS device used: FDA K071951 * Patients will be treated with standard physical therapy, including the electrical stimulation. Manual therapy, cold/heat therapy or exercise will be applied at the discretion of the physical therapist for about 60 minutes in each session. Patient education and self-care instructions will be provided. TENS will also be performed in each session for about 30 minutes based on the typical PT guidelines, which will serve both as a part of the standard of care and as a placebo equivalent. It will typically be set at Normal/Modulate mode and 120 Hertz rate.
Noxipoint Therapy arm (NT)
EXPERIMENTALPatients will be treated with TENS following Noxipoint Therapy guidelines as highlighted below: * The TENS device used: FDA K071951 * TENS is calibrated to allow for maximum range in the specifications. * A pair of electrode pads is placed at the corresponding pair of Noxipoints of the injured muscle/soft tissue, for about 2- 5 minutes during each application. * The electrical stimulation is set to induce the C-fiber response based on the feedback of the patient. * If the corresponding pain is not eliminated or reduced after a couple of applications on correct Noxipoints, apply an ice pack for about 10-15 minutes on site before and during the next Noxipoint stimulation.
Interventions
• For severe chronic neck pain patients, cervical braces are recommended within the first 2-3 days of each treatment session. The patient has to avoid using the treated tissues/muscles during the "Rest Period": Similar to all other cells, the muscle cell healing or regeneration takes time. Patients are instructed not to use the newly recovered muscle/tissue during the "Rest Period", which is about three days if they are forty or younger, plus about one extra day for every 10 additional years of age. If the patient has extensive injured muscles, take two more days of rest. Ice packs may be used during or soon after the session to prevent Delayed Onset of Muscle Soreness (DOMS) from the TENS stimulation.
•Placebo effect consideration: TENS is included in both arms to obfuscate the process. Using TENS in the PT arm serves both as a sham-therapy-equivalent to what is used in the NT arm to neutralize placebo bias, and as a meaningful therapeutic remedy. The subject is thus blinded. Placebo effect consideration: TENS is included in both arms to obfuscate the process. Using TENS in the PT arm serves both as a sham-therapy-equivalent to what is used in the NT arm to neutralize placebo bias, and as a meaningful therapeutic remedy. The subject is thus blinded.
Eligibility Criteria
You may qualify if:
- to 70 years of age
- Diagnosed as chronic cervical pain syndrome (ICD9: 723.1)
- Having no less than 6 months of the pain history
- The pain level \>= 5 in BPI
- with trigger points.
You may not qualify if:
- cervical spondylosis
- local corticoid injection within last two weeks
- signs of psychosomatic illness
- unwilling to be randomized
- pregnant woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Taiwan University Hospitallead
- Pain Cure Center, Californiacollaborator
Study Sites (1)
National Taiwan University Hospital
Taipai, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tyng-Guey Wang, MD
National Taiwan University
- PRINCIPAL INVESTIGATOR
Charles C Koo, PhD
National Taiwan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2013
First Posted
May 1, 2013
Study Start
April 1, 2013
Primary Completion
October 1, 2014
Study Completion
October 1, 2014
Last Updated
December 2, 2014
Record last verified: 2014-12